Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 4,735

Document Document Title
WO/2014/110277
The invention relates to the use of scyllo-inositol in treating personality disorders, in particular social withdrawal, as well as pharmaceutical compositions comprising effective amounts of scyllo-inositol for treating such disorders.  
WO/2014/110551
The present invention relates to antioxidant flavonoids, compositions containing such antioxidant flavonoids and methods for using such antioxidant flavonoids to treat, e.g., AMD.  
WO/2014/106473
Disclosed is use of glycyrrhetinic acid or glycyrrhizic acid in preventing or treating radiation injury of soft tissue. Therefore, glycyrrhetinic acid or glycyrrhizic acid can be used for preparing medicaments for preventing or treating ...  
WO/2014/103475
The purpose of the present invention is to provide a skin-exterior anti-ageing composition for preventing or improving trouble areas upon the exterior of the skin caused by ageing and degradation such as wrinkles, fine lines, blotches, a...  
WO/2014/104171
The purpose of the present invention is to provide a skin-exterior anti-ageing composition for preventing or improving trouble areas upon the exterior of the skin caused by ageing and degradation such as wrinkles, fine lines, blotches, a...  
WO/2014/100901
The invention is directed to a method of producing a peptide having antioxidant activity from barley hordein by treating barley hordein with alcalase at a sufficient time and temperature suitable for hydrolysis; and recovering the peptid...  
WO/2014/101366
The present invention relates to methods of treating one or more symptoms of a SHC-1/p66-related disease, inhibiting ROS generation or for the manufacture of a medicament in the above-mentioned treatment.  
WO/2014/104157
Provided is a method for simply producing a polyphenol composition which has excellent solubility in water and is in a solid state. A method for producing a polyphenol composition, which comprises the following steps (1) and (2). (1) a s...  
WO/2014/102692
The invention provides a composition comprising Lactobacillus fermentum ME-3 strain DSM 14241 for use in preventing, alleviating the symptoms of or treating, alone or as an adjuvant component,a metabolic syndrome related disorder selecte...  
WO/2014/100834
A composition and method for treating excess cyanide and hydrogen sulfide comprising administering a cobinamide. Further a method for determining extent of binding by an agent to an extracellular matrix.  
WO/2014/097284
This invention refers to a series of substances according to formula (I): and its synthesis process. The subtances according to formula I above, known as sulphated chelating agents have the ability to enlarge/loosen simple cell membranes...  
WO/2014/100088
The present invention is directed to concentrated liquid human milk fortifiers using extensively hydrolyzed casein as a protein source, a stabilizer system comprising octenyl succinic anhydride modified corn starch in combination with a ...  
WO/2014/096488
The invention relates to phenolic extracts containing procyanidins, propelargonidins and flavonolignans, that have properties/activities that are potentially beneficial for human health, and are obtained from the aerial parts and the inn...  
WO/2014/098092
Provided is a prophylactic/therapeutic agent for dry eye, which comprises a novel component capable of preventing the deterioration of a tear fluid secretion ability and also capable of inhibiting the generation of active oxygen in tear ...  
WO/2014/096437
The present invention relates to a nucleic acid molecule encoding a polypeptide, the polypeptide having the activity of alternative oxidase (AOX), wherein said nucleic acid molecule is selected from the group consisting of (a) a nucleic ...  
WO/2014/090183
Provided is a milk-derived biologically active polypeptide having an amino acid sequence of LPLP, which has in-vitro antioxidation activity and enhances immunity of human body. The polypeptide has good biological antioxidation activity, ...  
WO/2014/090180
Provided is a milk-derived biologically active polypeptide having an amino acid sequence of QEPV, which has in-vitro antioxidation activity and enhances immunity of human body. The polypeptide has good biological antioxidation activity, ...  
WO/2014/090184
Provided is a milk-derived biologically active polypeptide having an amino acid sequence of QEPVL, which has in-vitro antioxidation activity and promotes immune activity of human body. In-vitro antioxidation and in-vitro immunity promoti...  
WO/2014/092175
The present invention addresses the problem of providing a method for manufacturing a comparatively high-purity ≥4-mer polyphenol by precisely isolating said ≥4-mer polyphenol from a polyphenol mixture. This method for manufacturing ...  
WO/2014/090172
Provided is a milk-derived biologically active polypeptide having an amino acid sequence of DELQ, which has in-vitro antioxidation activity and promotes immune activity of human body. In-vitro antioxidation and in-vitro immunity promotio...  
WO/2014/086257
Disclosed in the present application is the use of a Yam glycoprotein in the preparation of drugs for treating nephritis and renal hypertension. The Yam glycoprotein comes from natural plants and can be prepared into various dosage forms...  
WO/2014/088200
The present invention provides a composition for preventing, alleviating or treating Th1-mediated immune diseases or Th2-mediated immune diseases, and provides a method for preventing, alleviating or treating Th1-mediated immune diseases...  
WO/2014/088631
Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of GLP-1, and/or naturally or artificially occurring variants or analogues of GLP-1, or pharmaceuticall...  
WO/2014/086102
The present invention relates to a compound having the general formula (I), a method of preparing the compound, a drug preparation containing the compound, and applications of the compound in preparing drugs used to preventing or treatin...  
WO/2014/086258
The present invention discloses that Yam glycoprotein can improve the activity of the key enzyme of brain cell mitochondria for oxidative metabolism, i.e., pyruvate dehydrogenase and α-ketoglutarate dehydrogenase, and thus can be used f...  
WO/2014/089482
The present invention provides a solid form and compositions thereof, which are useful as metal chelators and which exhibit desirable characteristics for the same.  
WO/2014/084027
A chimeric protein comprising FGF1 or FGF2 fused to CPP that contains the CPP-C domain of FGF11, FGF12, FGF13 or FGF14; and a DNA molecule containing a DNA sequence encoding FGF1 or FGF2 and a DNA sequence encoding CPP-C, or a vector con...  
WO/2014/079020
A pharmaceutical composition used for reducing the damage caused by free radicals is disclosed. The composition comprises at least a metal or its ions, at least a drug or an antioxidant that is carrier-protected/modified, and a drug carr...  
WO/2014/082046
The present invention relates to trisodium diethylenetriamine pentaacetic acid (DTPA) di-ethyl esters. The invention further relates to compositions comprising DTPA di-ethyl esters and methods of using the same.  
WO/2014/077409
The present invention relates to a method for mitigating a side effect of sunitinib by using the sunitinib and an antioxidant jointly with each other. It was discovered that the side effect of sunitinib is caused by an increase in oxidat...  
WO/2014/073450
The present invention addresses the problem of providing a drunkenness-relieving agent which can relieve the severity of a badly or heavily drunk state in heavy alcohol use. The means for solving the problem is the use of an insoluble co...  
WO/2014/074007
The invention relates to medicine, and more specifically to pharmaceutical agents which can be used for protecting a skin covering from harmful factors of a chemical and biological nature. What is claimed is a therapeutic dermatologic...  
WO/2014/071892
The present invention provides methods of modulating the deacetylase activity of SIRT1 by modifying the binding affinity of lamin Ato SIRT1 via interaction modifying compound. The present invention also provides methods of screening SIRT...  
WO/2014/071389
Described herein is the surprising discovery that ketone bodies protect cell and tissues from ionizing radiation. Based on this finding, methods of protecting animal tissue and cells from damage caused by radiation exposure are disclosed...  
WO/2014/070038
The invention relates to the pharmaceutical industry and the field of medicine and can be used in the creation and administration of solid dosage forms having neuroprotective, antiamnesic, antioxidant, antihypoxic and anti-ischemic activ...  
WO/2014/069682
The present invention relates to a monoclonal antibody for inducing apoptosis by binding to a cancer cell and a medical use thereof, and the antibody according to the present invention exhibits activity for cancer cell line-specific bind...  
WO/2014/065369
The purpose of the present invention is to provide a tea leaf extract rich in high-stability anthocyanin and exceptional palatability. Specifically, the present invention provides a tea leaf extract containing, with respect to the dry we...  
WO/2014/065275
The purpose of the present invention is to provide a novel therapeutic or prophylactic agent for tumor lysis syndrome. The present invention is a therapeutic or prophylactic agent for tumor lysis syndrome, which comprises a 2-phenylthiaz...  
WO/2014/060586
The present invention concerns a new family of 2,3-dihydroquinazolin-4(1H)-one compounds of general formula (I), and the use thereof as inhibitors of the toxic effects of toxins with intracellular activity, such as ricin or Shiga toxin, ...  
WO/2014/061783
The present invention provides: a novel human-derived monoclonal antibody which can bind specifically to each of toxins (toxin A and toxin B) produced from Clostridium difficile to exsert an excellent neutralizing activity, and an antige...  
WO/2014/056070
The present invention includes methods of preventing or minimizing cancer therapy induced alopecia (hair loss) in a subject, the method including administering to the subject an effective amount of (-)-deprenyl, a related compound, or a ...  
WO/2014/057073
A compound which is selected from A, B and C, and salts and solvates thereof, as well as conjugates thereof with cell binding agents.  
WO/2014/057120
Conjugates of an antibody that binds to CD25 with PBD dimers.  
WO/2014/057117
Conjugates of an antibody that binds to CD19 with PBD dimers.  
WO/2014/057119
Conjugates of an antibody that binds to CD25 with PBD dimers.  
WO/2014/054005
The invention involves the preparation of cholesterol lecithin nanosomes, without propylene glycol, from the complex formed by quercetin (or another flavonol or flavone or a derivative thereof) and 2-hydroxypropyl-β-cyclodextrin, by mea...  
WO/2014/055629
The present disclosure provides compounds of formula (I): compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased ...  
WO/2014/047715
The use of cholesterol-sequestering agents, such as methyl-beta-cyclodextrin, for the treatment of pulmonary surfactant dysfunction is disclosed. It was discovered that oxidative damage to pulmonary surfactant arises due to the interacti...  
WO/2014/048106
An ant watered pill containing traditional Chinese medicines and a preparation method thereof. The ant watered pill containing traditional Chinese medicines is prepared from the following raw materials by weight: 700-800g of polyrhachis ...  
WO/2014/048070
The present invention provides a composition for promoting erythropoiesis and uses thereof. The composition comprises two or more flavonoid compounds as active ingredients. The flavonoid compound is represented by formula I. R1 is hydrox...  

Matches 1 - 50 out of 4,735